Therefore, inhibiting key mediators of gluconeogenesis – such as glucose-6-phosphatase and fructose-1,6-bisphosphatase – alongside enhancing insulin production (which naturally suppresses gluconeogenic enzymes), may represent an effective approach to diabetes management. This evidence concerns the gene FBP1 and diabetes mellitus.